Imeglimin beneficial as add-on to metformin in T2DM
(HealthDay)—For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, ...
Diabetes
Dec 14, 2012 |
not rated yet |
0
Metformin improves blood glucose levels and BMI in very obese children
Metformin therapy has a beneficial treatment effect over placebo in improving body mass index (BMI) and fasting glucose levels in obese children, according to a recent study accepted for publication in The Endocrine Society's ...
Diabetes
Dec 10, 2012 |
5 / 5 (3) |
0
Common diabetes drug may help treat ovarian cancer
A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer ...
Cancer
Dec 03, 2012 |
5 / 5 (2) |
0
Sulfonylureas up cardio events versus metformin
(HealthDay)—Use of sulfonylureas for initial treatment of diabetes is associated with increased cardiovascular events and death compared with metformin, according to a study published in the Nov. 6 issue ...
Medications
Nov 07, 2012 |
not rated yet |
0
Popular diabetes meds put to the test
(HealthDay)—Patients with diabetes who were treated with the popular oral medication metformin face a lower risk of heart attack, stroke or death than those taking sulfonylureas, another common option, ...
Diabetes
Nov 06, 2012 |
5 / 5 (2) |
0
Considerably more patients may benefit from effective antidiabetic drug
The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, ...
Diabetes
Sep 17, 2012 |
not rated yet |
0
Lung cancer risk unaffected by metformin use in diabetes
(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.
Diabetes
Aug 30, 2012 |
5 / 5 (1) |
0
32-country study shows that type 2 diabetes drug is clinically effective for long-term use
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination ...
Diabetes
Jul 23, 2012 |
5 / 5 (1) |
0
|
Early intensive diabetes therapy preserves beta-cell function
(HealthDay) -- Early, intensive therapy for type 2 diabetes with either insulin plus metformin or triple oral therapy preserves β-cell function for at least 3.5 years, according to a study published in ...
Diabetes
Jul 06, 2012 |
not rated yet |
0
Diabetes drug metformin makes brain cells grow
The widely used diabetes drug metformin comes with a rather unexpected and alluring side effect: it encourages the growth of new neurons in the brain. The study reported in the July 6th issue of Cell Stem Cell also finds ...
Medical research
Jul 05, 2012 |
5 / 5 (8) |
1
|
Study shows treating diabetes early, intensively is best strategy
Intensive early treatment of type 2 diabetes slows down progression of the disease by preserving the body's insulin-producing capacity, a UT Southwestern study has shown.
Diabetes
Jun 28, 2012 |
5 / 5 (1) |
0
|
Metformin may lower cancer risk in people with Type 2 diabetes
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results to be presented at The Endocrine Society's 94th Annual Meeting ...
Diabetes
Jun 25, 2012 |
not rated yet |
0
Common diabetes drugs associated with increased risk of death
Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death, a large new analysis finds. The results will be presented at The Endocrine Society's 94th Annual Meeting ...
Diabetes
Jun 25, 2012 |
not rated yet |
0
Metformin treatment caused cancer stem cell death in pancreatic cancer cell lines
Results of some preclinical trials have shown that low doses of the antidiabetic drug metformin may effectively destroy cancer stem cells, a group of cells that are considered to be responsible for tumor initiation and, because ...
Cancer
Jun 19, 2012 |
not rated yet |
0
Diabetes drug metformin may cut breast cancer risk in older women
(HealthDay) -- A widely prescribed drug, metformin, may lower the risk of invasive breast cancer in postmenopausal women with diabetes, a new study indicates.
Cancer
Jun 11, 2012 |
not rated yet |
0
